课题基金 / 基金详情

TREATMENT OF BRAIN TUMORS WITH 2-5A-ANTITELOMERASE RNA

TREATMENT OF BRAIN TUMORS WITH 2-5A-ANTITELOMERASE RNA
用 2-5A-抗端粒酶 RNA 治疗脑肿瘤
批准号：
6137724
负责人：
SEIJI KONDO
金额：
$3.43万
依托单位：
CLEVELAND CLINIC FOUNDATION
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
项目状态：
已结题
起止时间：
1999-01-01 至 2000-02-29
来源：
https://reporter.nih.gov/project-details/6137724
关键词：
DNA replication antisense nucleic acid apoptosis athymic mouse cis platinum compound combination cancer therapy complementary RNA cyclin dependent kinase cytotoxicity disease /disorder model drug screening /evaluation endoribonucleases enzyme activity enzyme inhibitors gene targeting glioma histopathology neoplasm /cancer chemotherapy neoplasm /cancer radiation therapy neoplastic cell nonhuman therapy evaluation oligonucleotides pharmacokinetics telomerase tissue /cell culture

项目成果

SEIJI KONDO的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Treatment of Malignant Gliomas with 2-5A-anti-hTR
Treatment of Malignant Gliomas with 2-5A-anti-hTR
Treatment of Malignant Gliomas with 2-5A-anti-hTR
Telomerase Specific Caspase Transfer for Gliomas
海外基金